Vaccine safety and reporting adverse events

The Therapeutic Goods Administration (TGA) assesses all vaccines in Australia. This ensures that in order for a vaccine to be approved it is safe, effective and manufactured to a very high quality standard. A description of the process for approval of COVID-19 vaccines is available on the TGA website.

The safety of COVID-19 vaccines will be monitored continuously throughout the COVID-19 vaccination program. 

If you would prefer to report it yourself, please visit the TGA website for information on how to report suspected side effects associated with COVID-19 vaccines.

SMARTVAX - How it works

An automated text message and smartphone survey is sent to patients on days 3, 8 and 42, following their COVID-19 immunisation. The message asks whether the patient experienced a reaction to the vaccine and invites them to provide further information regarding the nature, severity and duration of any reactions experienced.  GPs are notified via their practice software inbox  of any significant reactions experienced by their patients, so that patient records can be updated and additional care arranged if needed.

SmartVax-logosmall.png